Xia Zhou

127 Changle West Road
Xi'an, 710032, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Three-Dimensional Aggregate Culture Enhances the Therapeutic Efficacy of Human Umbilical Cord-Derived Mesenchymal Stem Cells in the Mouse Model of Metabolic Dysfunction-Associated Steatohepatitis.

Three-Dimensional Aggregate Culture Enhances the Therapeutic Efficacy of Human Umbilical Cord-Derived Mesenchymal Stem Cells in the Mouse Model of Metabolic Dysfunction-Associated Steatohepatitis.

Journal: Stem cells and development

Published: April 16, 2026

The heterogeneity of monocyte-derived macrophages in MASH pathogenesis.

The heterogeneity of monocyte-derived macrophages in MASH pathogenesis.

Journal: Cell communication and signaling : CCS

Published: August 13, 2025

Extracellular vesicles derived from live or apoptotic mesenchymal stem cells: comparison of the effects of two extracellular vesicles on liver fibrosis.

Extracellular vesicles derived from live or apoptotic mesenchymal stem cells: comparison of the effects of two extracellular vesicles on liver fibrosis.

Journal: BMC gastroenterology

Published: June 25, 2025

Off-the-shelf human umbilical cord mesenchymal stromal cell product in acute-on-chronic liver failure: A multicenter phase I/II clinical trial.

Off-the-shelf human umbilical cord mesenchymal stromal cell product in acute-on-chronic liver failure: A multicenter phase I/II clinical trial.

Journal: Chinese medical journal

Published: April 27, 2025

A case report of liver failure caused by Tetrastigma hemsleyanum Diels et Gilg: A rare case report and literature review.

A case report of liver failure caused by Tetrastigma hemsleyanum Diels et Gilg: A rare case report and literature review.

Journal: Medicine

Published: March 28, 2025

Engineered Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Mitigate Liver Fibrosis by Delivering USP10 to Reprogram Macrophage Phenotype.

Engineered Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Mitigate Liver Fibrosis by Delivering USP10 to Reprogram Macrophage Phenotype.

Journal: Biomaterials research

Published: March 27, 2025

Role of the FOXM1/CMA/ER stress axis in regulating the progression of nonalcoholic steatohepatitis.

Role of the FOXM1/CMA/ER stress axis in regulating the progression of nonalcoholic steatohepatitis.

Journal: Clinical and translational medicine

Published: June 12, 2024

Native and engineered extracellular vesicles: novel tools for treating liver disease.

Native and engineered extracellular vesicles: novel tools for treating liver disease.

Journal: Journal of materials chemistry. B

Published: March 27, 2024

Host FSTL1 defines the impact of stem cell therapy on liver fibrosis by potentiating the early recruitment of inflammatory macrophages.

Host FSTL1 defines the impact of stem cell therapy on liver fibrosis by potentiating the early recruitment of inflammatory macrophages.

Journal: Signal transduction and targeted therapy

Published: February 17, 2024

Identifying optimal candidates for autologous peripheral blood stem cell therapy in patients with decompensated liver cirrhosis: a prognostic scoring system.

Identifying optimal candidates for autologous peripheral blood stem cell therapy in patients with decompensated liver cirrhosis: a prognostic scoring system.

Journal: Stem cell research & therapy

Published: January 31, 2023

Deficient chaperone-mediated autophagy in macrophage aggravates inflammation of nonalcoholic steatohepatitis by targeting Nup85.

Deficient chaperone-mediated autophagy in macrophage aggravates inflammation of nonalcoholic steatohepatitis by targeting Nup85.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: August 14, 2022

Prediction and evaluation of high-risk patients with primary biliary cholangitis receiving ursodeoxycholic acid therapy: an early criterion.

Prediction and evaluation of high-risk patients with primary biliary cholangitis receiving ursodeoxycholic acid therapy: an early criterion.

Journal: Hepatology international

Published: July 31, 2022

Showing 1-12 of 27

Last Updated: 09/26/2026